BioTissue Surgical is the leader in amniotic membrane and umbilical cord regenerative tissue therapies and is supported by more than 30 years of research characterizing and preserving the biology and functionality of human Amniotic Membrane (AM) and Umbilical Cord (UC). AM and UC are restorative tissues that carry unique regenerative properties and BioTissue Surgical is the sole provider of a matrix comprised of both human AM and UC. Our extensive research allows us to preserve and deliver the most functional allograft, transplanting the benefits of regenerative healing to adult wound environments.
Company Details
- Employees
- 27
- Founded
- -
- Address
- 7300 Corporate Center Dr, Miami,florida 33126,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Miami, Florida
Biotissue Surgical Questions
Biotissue Surgical's website is https://biotissue.com/products/biotissue-surgical/
Biotissue Surgical's LinkedIn profile is https://www.linkedin.com/company/biotissue-surgical
Biotissue Surgical has
27 employees.
View email and phone details for 27
employees at Biotissue Surgical.
Biotissue Surgical's industry is
Biotechnology Research
Biotissue Surgical's top competitors are
Mimedx,
Vivex Biologics,
Biotissue Ocular,
Kerecis,
Biotissue,
Bioventus,
Mtf Biologics,
New Horizon Medical Solutions,
Integra Lifesciences,
Organogenesis.
Biotissue Surgical's categories are Biotechnology Research
Biotissue Surgical's founding year is 2011
